Elliot Norry, Chief Medical Officer at Adaptimmune Therapeutics PLC (ADAP), sold 22,195 shares at $0.57 ($13K) on 2025-01-15, disclosed to the SEC on 2025-01-15.
Seasonal sale ($13k) by Chief Medical Officer — this insider has traded ADAP in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.59 | 4,268 | $3K | 19.5% |
| 2 | $0.59 | 8,124 | $5K | 37.2% |
| 3 | $0.57 | 9,803 | $6K | 43.3% |
| Total | $0.58 avg | 22,195 | $13K | 100% |
| Filing → |
| ADAP | SELL | 2024-01-12 | $10K | — | Filing → |
| ADAP | SELL | 2023-01-17 | $4K | — | Filing → |
| ADAP | SELL | 2023-01-12 | $19K | — | Filing → |